...
首页> 外文期刊>Drug development and industrial pharmacy >Development of biofilm-targeted antimicrobial wound dressing for the treatment of chronic wound infections
【24h】

Development of biofilm-targeted antimicrobial wound dressing for the treatment of chronic wound infections

机译:生物膜靶向抗菌伤口敷料的开发,用于治疗慢性伤口感染

获取原文
获取原文并翻译 | 示例
           

摘要

It has been established that microbial biofilms are largely responsible for the recalcitrance of many wound infections to conventional antibiotics. It was proposed that the efficacy of antibiotics could be optimized via the inhibition of bacterial biofilm growth in wounds. The combination of antibiofilm agent and antibiotics into a wound dressing may be a plausible strategy in wound infection management. Xylitol is an antibiofilm agent that has been shown to inhibit the biofilm formation. The purpose of this study was to develop an alginate film containing xylitol and gentamicin for the treatment of wound infection. Three films, i.e. blank alginate film (SA), alginate film with xylitol (F5) and alginate film with xylitol and gentamicin (AG), were prepared. The films were studied for their physical properties, swelling ratio, moisture absorption, moisture vapor transmission rate (MVTR), mechanical and rheology properties, drug content uniformity as well as in vitro drug release properties. Antimicrobial and antibiofilm in vitro studies on Staphylococcus aureus and Pseudomonas aeruginosa were also performed. The results showed that AG demonstrates superior mechanical properties, rheological properties and a higher MVTR compared with SA and F5. The drug flux of AG was higher than that of commercial gentamicin cream. Furthermore, antimicrobial studies showed that AG is effective against both S. aureus and P. aeruginosa, and the antibiofilm assays demonstrated that the combination was effective against biofilm bacteria. In summary, alginate films containing xylitol and gentamicin may potentially be used as new dressings for the treatment of wound infection.
机译:已经确定,微生物生物膜是许多伤口感染对常规抗生素的顽抗的主要原因。有人提出,可以通过抑制伤口中细菌生物膜的生长来优化抗生素的功效。在伤口敷料中结合使用抗生物膜剂和抗生素可能是伤口感染管理中可行的策略。木糖醇是一种抗生物膜剂,已被证明可以抑制生物膜的形成。这项研究的目的是开发一种含有木糖醇和庆大霉素的藻酸盐薄膜,用于治疗伤口感染。制备三层膜,即空白藻酸盐膜(SA),具有木糖醇的藻酸盐膜(F5)和具有木糖醇和庆大霉素的藻酸盐膜(AG)。研究了薄膜的物理性能,溶胀率,吸湿率,水蒸气透过率(MVTR),机械和流变性能,药物含量均匀性以及体外药物释放性能。还对金黄色葡萄球菌和铜绿假单胞菌进行了体外抗菌和生物膜研究。结果表明,与SA和F5相比,AG具有优良的机械性能,流变性能和更高的MVTR。 AG的药物通量高于商业庆大霉素乳膏。此外,抗菌研究表明AG对金黄色葡萄球菌和铜绿假单胞菌均有效,而抗生物膜试验表明该组合对生物膜细菌有效。总之,含有木糖醇和庆大霉素的藻酸盐膜可能被用作治疗伤口感染的新敷料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号